Understanding Outcomes for Babies Exposed to Opioids Before Birth
HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium
['FUNDING_OTHER'] · RESEARCH TRIANGLE INSTITUTE · NIH-11145265
This project helps us learn about the health and development of children who were exposed to opioids before they were born.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RESEARCH TRIANGLE INSTITUTE (nih funded) |
| Locations | 1 site (RESEARCH TRIANGLE PARK, UNITED STATES) |
| Trial ID | NIH-11145265 on ClinicalTrials.gov |
What this research studies
This long-term project follows children from birth to understand how being exposed to opioids before birth affects their health, brain development, and behavior. We are looking at how their brains grow and connect, as well as their overall medical and developmental progress. The project also considers how factors like the home environment and a mother's mental health might influence a child's development. This grant supports the coordination and data management for the ongoing study.
Who could benefit from this research
Good fit: This project focuses on children who were exposed to opioids during pregnancy and a comparison group of unexposed children, followed from birth through their early years.
Not a fit: Patients not directly involved in this specific longitudinal follow-up cohort would not receive direct benefit from this particular data coordinating center grant.
Why it matters
Potential benefit: This work could lead to better ways to support and care for children who were exposed to opioids before birth, helping them achieve their best possible health and development.
How similar studies have performed: This is a continuation of an ongoing longitudinal cohort study, building on existing data and protocols to further understand long-term outcomes.
Where this research is happening
RESEARCH TRIANGLE PARK, UNITED STATES
- RESEARCH TRIANGLE INSTITUTE — RESEARCH TRIANGLE PARK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BANN, CARLA M — RESEARCH TRIANGLE INSTITUTE
- Study coordinator: BANN, CARLA M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.